Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chester

Showing results (241-250 of 264) with videos related to

Pageof 27
Sort By:
Mabs|October 1, 2015
Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CAPaul W H I Parren, Dennis R Burton, Andrew Bradbury, et al.
Cell|October 10, 1997
Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamineM Rubinstein, T J Phillips, J R Bunzow, et al.
Mabs|December 18, 2014
Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014James W Larrick, Paul W H I Parren, James S Huston, et al.
Journal of General Internal Medicine|January 21, 2006
Laboratory monitoring of drugs at initiation of therapy in ambulatory careMarsha A Raebel, Ella E Lyons, Susan E Andrade, et al.
The Journal of Pathology|February 5, 2011
Stromal features are predictive of disease mortality in oral cancer patientsDaniel Marsh, Krishna Suchak, Karwan A Moutasim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 28, 2026
Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplantJenny Yeung, Aiyin Liao, Matthew Shaw, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2024
Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplantJenny Yeung, Aiyin Liao, Matthew Shaw, et al.
Mabs|August 26, 2016
Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CAJames W Larrick, Mark R Alfenito, Jamie K Scott, et al.
International Journal of Cancer|April 21, 2015
Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumorsMartin C Boonstra, Berend Tolner, Boudewijn E Schaafsma, et al.
Journal of Molecular Biology|January 8, 1999
The structure of vitellogenin provides a molecular model for the assembly and secretion of atherogenic lipoproteinsC J Mann, T A Anderson, J Read, et al.
Pageof 27

Showing results (241-250 of 264) with videos related to

Sort By:
Pageof 27
Mabs|October 1, 2015
Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CAPaul W H I Parren, Dennis R Burton, Andrew Bradbury, et al.
Cell|October 10, 1997
Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamineM Rubinstein, T J Phillips, J R Bunzow, et al.
Mabs|December 18, 2014
Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014James W Larrick, Paul W H I Parren, James S Huston, et al.
Journal of General Internal Medicine|January 21, 2006
Laboratory monitoring of drugs at initiation of therapy in ambulatory careMarsha A Raebel, Ella E Lyons, Susan E Andrade, et al.
The Journal of Pathology|February 5, 2011
Stromal features are predictive of disease mortality in oral cancer patientsDaniel Marsh, Krishna Suchak, Karwan A Moutasim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 28, 2026
Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplantJenny Yeung, Aiyin Liao, Matthew Shaw, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2024
Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplantJenny Yeung, Aiyin Liao, Matthew Shaw, et al.
Mabs|August 26, 2016
Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CAJames W Larrick, Mark R Alfenito, Jamie K Scott, et al.
International Journal of Cancer|April 21, 2015
Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumorsMartin C Boonstra, Berend Tolner, Boudewijn E Schaafsma, et al.
Journal of Molecular Biology|January 8, 1999
The structure of vitellogenin provides a molecular model for the assembly and secretion of atherogenic lipoproteinsC J Mann, T A Anderson, J Read, et al.
Pageof 27